GlassScriptPhysician profile
Ashley B Cafferty
NPI 1215001417
$467.83
in general payments reported to CMS, 2019-2025
12 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.36 · 2022: $24.48 · 2023: $29.92 · 2024: $111 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $155.77 | 2021-2025 | Opzelura, Opzelura |
| Ucb, INC. | $90.96 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $38.93 | 2024-2025 | |
| Reprise Biomedical, INC. | $31.73 | 2025 | Miro3d |
| Mimedx Group, INC. | $30.48 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $24.48 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.13 | 2021 | |
| Leo Pharma INC. | $18.73 | 2025 | Adbry |
| Genentech USA, INC. | $18.24 | 2021 | |
| Revance Therapeutics, INC. | $14.83 | 2025 | Daxxify |
| Janssen Biotech, INC. | $14.38 | 2023 | Tremfya |
| Sensus Healthcare, INC. | $10.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Cafferty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.